Physician Wealth Advisors Inc. Buys 5,092 Shares of Huntsman Co. (NYSE:HUN)

Physician Wealth Advisors Inc. lifted its position in Huntsman Co. (NYSE:HUN) by 27.4% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 23,676 shares of the basic materials company’s stock after buying an additional 5,092 shares during the quarter. Physician Wealth Advisors Inc.’s holdings in Huntsman were worth $553,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its position in shares of Huntsman by 1.5% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 6,657,819 shares of the basic materials company’s stock valued at $151,599,000 after acquiring an additional 97,082 shares during the period. Millennium Management LLC grew its holdings in Huntsman by 5.2% during the second quarter. Millennium Management LLC now owns 4,891,928 shares of the basic materials company’s stock worth $111,389,000 after purchasing an additional 243,821 shares during the period. 1832 Asset Management L.P. increased its position in Huntsman by 54.0% during the second quarter. 1832 Asset Management L.P. now owns 4,415,264 shares of the basic materials company’s stock worth $100,536,000 after buying an additional 1,547,344 shares during the last quarter. Wellington Management Group LLP raised its stake in Huntsman by 75.9% in the fourth quarter. Wellington Management Group LLP now owns 3,151,535 shares of the basic materials company’s stock valued at $79,198,000 after buying an additional 1,359,437 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its position in shares of Huntsman by 9.2% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,408,592 shares of the basic materials company’s stock valued at $62,697,000 after buying an additional 203,396 shares during the last quarter. 84.81% of the stock is currently owned by institutional investors and hedge funds.

Huntsman Stock Up 0.6 %

Shares of HUN opened at $23.52 on Thursday. The company has a current ratio of 1.30, a quick ratio of 0.77 and a debt-to-equity ratio of 0.40. Huntsman Co. has a 12 month low of $19.91 and a 12 month high of $27.01. The firm’s 50 day moving average is $22.23 and its 200-day moving average is $23.30. The stock has a market capitalization of $4.07 billion, a PE ratio of -45.23 and a beta of 1.00.

Huntsman (NYSE:HUN) last released its earnings results on Monday, August 5th. The basic materials company reported $0.14 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.14. Huntsman had a positive return on equity of 0.26% and a negative net margin of 1.44%. The firm had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.61 billion. During the same period in the prior year, the company posted $0.22 EPS. The company’s revenue was down 1.4% compared to the same quarter last year. Equities research analysts forecast that Huntsman Co. will post 0.19 EPS for the current year.

Huntsman Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Friday, September 13th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 4.25%. The ex-dividend date of this dividend was Friday, September 13th. Huntsman’s payout ratio is presently -192.31%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on HUN. Royal Bank of Canada boosted their target price on Huntsman from $21.00 to $24.00 and gave the stock a “sector perform” rating in a report on Friday, October 11th. JPMorgan Chase & Co. dropped their price objective on shares of Huntsman from $27.00 to $25.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 7th. Wells Fargo & Company reduced their target price on shares of Huntsman from $28.00 to $26.00 and set an “overweight” rating for the company in a report on Wednesday, August 7th. Citigroup lowered their price target on shares of Huntsman from $26.00 to $24.00 and set a “neutral” rating on the stock in a report on Thursday, June 27th. Finally, UBS Group reduced their price objective on Huntsman from $23.00 to $22.00 and set a “neutral” rating for the company in a report on Tuesday, August 6th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $25.89.

Huntsman Profile

Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.